Moss Adams Wealth Advisors »

Avenue Therapeutics shares owned by Moss Adams Wealth Advisors

Quarter-by-quarter ownership of Avenue Therapeutics (ATXI) shares owned by Moss Adams Wealth Advisors from 13F filings

Historical chart of Moss Adams Wealth Advisors investment in Avenue Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avenue Therapeutics held by Moss Adams Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avenue Therapeutics by Moss Adams Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $27k 11k 2.49

More positions owned by Moss Adams Wealth Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p Scp Etf (IJR)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Global X Fds Cybrscurty Etf (BUG)
Global X Fds Us Infr Dev Etf (PAVE)
Vaneck Etf Trust Semiconductr Etf (SMH)
Select Sector Spdr Tr Communication (XLC)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr Russell 3000 Etf (IWV)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr National Mun Etf (MUB)

View all positions for Moss Adams Wealth Advisors

Top funds holding Avenue Therapeutics

Armistice Capital
Moss Adams Wealth Advisors
Tower Research Capital
Wells Fargo & Company
Bank of America Corporation
Emfo
Jpmorgan Chase & Co

View all funds holding Avenue Therapeutics